Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.
about
Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy.Neuroprotection of medical IOP-lowering therapy.Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucomaOxidative Stress-Related Molecular Biomarker Candidates for Glaucoma.Activation of muscarinic receptors protects against retinal neurons damage and optic nerve degeneration in vitro and in vivo models.Evaluation of potential topical and systemic neuroprotective agents for ocular hypertension-induced retinal ischemia-reperfusion injury.
P2860
Q34953629-6CEFFE98-990A-454D-85C1-FF277C5C88A5Q37179493-22D32236-784D-47DB-A6AE-D3DD4665160CQ38120187-B3E50AC6-1280-4CED-9BEB-B348743D7970Q38366857-E5F469A2-0FB4-4605-BE96-803ADD9B0A3AQ41661667-45A10199-38D0-4E44-8F31-16CC5F161924Q47106263-642D2DFF-0F97-4A3F-833D-581DC09420CAQ50227757-85DBC3FA-26A5-4739-948A-FB57ED61B3F4Q50484130-27ACAC8F-3B47-46DE-93ED-31B641117BD1
P2860
Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Secondary neuroprotective effe ...... otential mechanisms of action.
@ast
Secondary neuroprotective effe ...... otential mechanisms of action.
@en
type
label
Secondary neuroprotective effe ...... otential mechanisms of action.
@ast
Secondary neuroprotective effe ...... otential mechanisms of action.
@en
prefLabel
Secondary neuroprotective effe ...... otential mechanisms of action.
@ast
Secondary neuroprotective effe ...... otential mechanisms of action.
@en
P2860
P356
P1476
Secondary neuroprotective effe ...... otential mechanisms of action.
@en
P2093
David J Calkins
Grace C Shih
P2860
P304
P356
10.1586/EOP.12.13
P577
2012-04-01T00:00:00Z